Valneva SE (VALN) Gross Profit (2021 - 2026)
Valneva SE (VALN) posted Gross Profit of $5.5 million for Q1 2026, up 95.6% sequentially from $2.8 million in Q4 2025, and down 79.92% YoY from $27.5 million in Q1 2025.
Analysis
Valneva SE (VALN) Gross Profit (2021 - 2026) Analysis & Trends
Valneva SE has reported Gross Profit for 6 years, with the latest figure at $5.5 million in Q1 2026.
- Quarterly Gross Profit fell 79.92% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (down 61.24% YoY) and the FY2025 annual result came in at $59.1 million, down 15.7% from the prior year.
- Gross Profit advanced to $5.5 million in Q1 2026 per VALN's latest filing, from $2.8 million in the prior quarter.
- Over five years, Gross Profit peaked at $126.5 million in Q3 2022 and troughed at -$92.0 million in Q2 2022.
- A 5-year average of $13.0 million and a median of $14.0 million in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2022 and 2023: Gross Profit plunged 1937.35% in 2022, then jumped 261.9% in 2023.
- Over 5 years, Gross Profit stood at -$10.5 million in 2022, then surged by 261.9% to $17.0 million in 2023, then jumped by 47.83% to $25.2 million in 2024, then tumbled by 88.77% to $2.8 million in 2025, then surged by 95.6% to $5.5 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $5.5 million, $2.8 million, and -$2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Valneva SE | 588.63 Mn | 447.37 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 5.53 Mn |
| Dec 31, 2025 | 13.52 Mn |
| Sep 30, 2025 | 6.43 Mn |
| Jun 30, 2025 | 27.41 Mn |
| Mar 31, 2025 | 27.55 Mn |
| Dec 31, 2024 | 27.47 Mn |
| Sep 30, 2024 | 22.12 Mn |
| Jun 30, 2024 | 15.71 Mn |
| Mar 31, 2024 | 11.51 Mn |
| Dec 31, 2023 | 17.04 Mn |
| Sep 30, 2023 | 18.61 Mn |
| Jun 30, 2023 | 7.49 Mn |
| Mar 31, 2023 | 13.98 Mn |
| Dec 31, 2022 | -10.52 Mn |
| Sep 30, 2022 | 126.47 Mn |
| Jun 30, 2022 | -92.03 Mn |
| Mar 31, 2022 | 8.96 Mn |
| Dec 31, 2021 | 285.88 Mn |
| Sep 30, 2021 | -120.83 Mn |